Hepatitis Archives - Infectious Disease Advisor

Persistent High Rates of HBsAg Loss With IFN-α in Chronic HBV Suggestive of Its Potential

By

Sweta Gupta

September 23, 2020

Researchers conducted a retrospective medical chart review to analyze relationship between HBsAg loss and a single PEG(IFN-α) course.

Nine Cases of Wound Botulism ID'd in Injection Drug Users

Hepatitis

Cost-Effectiveness of Universal and Targeted Hepatitis C Screening

By

Bradley van Paridon

September 21, 2020

Researchers conducted a simulated economic evaluation cohort analyses to assess the cost-effectiveness of HCV screening and compared other screening programs in the United States.

Hepatitis

Persistent ALT Elevation in HIV-HBV Coinfection May Signal Coexisting Fatty Liver Disease

By

Sweta Gupta

September 16, 2020

Patients with persistent ALT elevation despite controlled HBV should undergo evaluation for metabolic risk and fatty liver disease.

Two studies characterize hematological recovery after CAR-T cell therapy.

Hepatitis

ASCO Issues Provisional Opinion Update on Hepatitis B Screening

By

Leah Lawrence

August 24, 2020

ASCO recommends that patients with newly diagnosed cancer slated to receive systemic anticancer meds be tested for HBV by 3 tests prior to starting therapy.

Hepatitis

Routine Hepatitis C Testing at Federally Qualified Health Centers Would Be Cost-Effective

July 28, 2020

Routine hepatitis C virus (HCV) testing at federally qualified health centers (FQHCs) would be cost-effective and could improve outcomes for people with HCV infections.

The Denver City Council recently passed an ordinance to allow the nation’s first supervised injection site. The Colorado General Assembly must also render an approval. A bipartisan bill to allow the site narrowly failed in a Republican-controlled Senate in 2018, but party control will change in 2019, making its passage more likely.3 Meanwhile, cities including San Francisco and Philadelphia are moving forward with their own site plans, despite warnings from the US Justice Department. Whether in Denver, San Francisco, Philadelphia, or elsewhere, expect the first supervised injection site in the United States to open in the near future, and for a legal battle to follow.

Hepatitis

Efficacy of Bundled HIV, HCV Testing for People With Substance Abuse Disorders Examined

By

Bradley van Paridon

July 22, 2020

By providing bundled HIV and HCV testing, substance use disorder treatment programs may create increased awareness of infection status among people with substance abuse disorders.

COVID19

Small Case Series Describes Clinical Course of Patients With COVID-19 and Chronic HBV

By

Brandon May

July 20, 2020

Researchers found that no patients with concomitant COVID-19 and hepatitis B virus infection progressed to severe or critically ill status during hospitalization, but many had abnormal liver function tests on admission.

COVID19

Hepatitis B and C Virus Considerations in COVID-19

By

Tori Rodriquez, MA, LPC, AHC

July 15, 2020

Numerous reports have indicated gastrointestinal, cardiovascular, and neurologic manifestations, in addition to the noted respiratory effects, in patients with COVID-19, and up to 50% of patients with COVID-19 may experience hepatic manifestations.

Hepatitis

Besifovir Dipivoxil Maleate Effective, Safe for Long-Term Treatment of Chronic Hepatitis B

By

Emily Pond

June 11, 2020

Study data supports the long-term efficacy and safety of besifovir dipivoxil maleate (BSV) for the treatment of chronic hepatitis B (CHB).

Hepatitis

Universal Testing May Help Identify HCV in Pediatric Population

By

Zahra Masoud

April 24, 2020

New polices, including testing for hepatitis C virus (HCV) during pregnancy, may increase HCV identification in the pediatric population by addressing gaps in maternal HCV testing.